SEER INC.
-
USD
(-)
- 15 min delayed data - NASDAQ Stocks
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | SEER |
| ISIN: |
SEER INC. news, videos and press releases
For more news please use our advanced search feature.
SEER INC. - More news...
SEER INC. - More news...
- 02/27/2025 - 21:05 Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
- 02/21/2025 - 12:00 Seer to Participate in the TD Cowen 45th Annual Health Care Conference
- 02/20/2025 - 12:00 Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
- 02/13/2025 - 21:15 Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
- 01/02/2025 - 21:05 Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
- 11/21/2024 - 21:05 Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
- 11/08/2024 - 12:00 Seer to Participate in Upcoming November Investor Conferences
- 11/06/2024 - 21:05 Seer Reports Third Quarter 2024 Financial Results
- 11/06/2024 - 21:03 Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
- 10/31/2024 - 11:00 Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
- 10/21/2024 - 11:00 Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
- 10/17/2024 - 20:05 Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
- 08/22/2024 - 20:05 Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- 08/14/2024 - 20:05 Seer Appoints Nicolas Roelofs to its Board of Directors
- 08/09/2024 - 11:00 Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
- 08/08/2024 - 20:05 Seer Reports Second Quarter 2024 Financial Results
- 07/18/2024 - 20:03 Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
- 06/11/2024 - 15:11 Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
- 06/02/2024 - 14:55 Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
- 05/08/2024 - 20:05 Seer Reports First Quarter 2024 Financial Results
- 05/08/2024 - 20:03 Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
- 04/23/2024 - 20:05 Seer to Report First Quarter 2024 Financial Results on May 8, 2024
- 02/29/2024 - 21:05 Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
- 02/21/2024 - 21:05 Seer to Participate in the TD Cowen 44th Annual Health Care Conference
- 02/06/2024 - 13:00 Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
- 02/01/2024 - 21:05 Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
- 12/21/2023 - 21:05 Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
- 11/10/2023 - 14:00 Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
- 11/08/2023 - 14:00 Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
- 11/07/2023 - 21:05 Seer Reports Third Quarter 2023 Financial Results
